Gladstone Home blank GIVI HOME
 
spacer
GIVI HOME

Gladstone Institutes Home  
Institute of
Cardiovascular Disease
GICD
 
Institute of
Neurological Disease
GIND
 
Center for
Translational
Research
CTR
University of California,
San Francisco
UCSF
 
Supporting Gladstone
Publications 1997
  • Ghoda L, Lin X, Greene WC (1997) The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkBa and stimulates its degradation in vitro. J. Biol. Chem. 272:21281–21288.

  • Goldsmith MA, Greene WC (1997) The interleukin-2 receptor. In: Growth Factors and Cytokines in Health and Disease. A Multi-volume Treatise (Bondy C, eds) JAI Press, Greenwich, CT, pp 355–402.

  • Gosling J, Monteclaro FS, Atchison RE, Arai H, Tsou C-L, Goldsmith MA, Charo IF (1997) Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA 94:5061–5066.

  • Greene WC (1997) Molecular insights into HIV-1 infection. In: The Medical Management of AIDS (Volberding PA, eds) W. B. Saunders, Philadelphia, pp 17–28.

  • Hellerstein MK, McCune JM (1997) T cell turnover in HIV-1 disease. Immunity 7:583–589.

  • Komanduri KV, Salha M-D, SZkaly R-P, McCune JM (1997) Superantigen-mediated deletion of specific T cell receptor Vb subsets in the SCID-hu Thy/Liv mouse is induced by staphylococcal enterotoxin B, but not HIV-1. J. Immunol. 158:544–549.

  • Lai SY, Molden J, Goldsmith MA (1997) Shared gc subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency. J. Clin. Invest. 99:169–177.

  • Liu KD, Gaffen SL, Goldsmith MA, Greene WC (1997) Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation. Curr. Biol. 7:817–826.

  • McCune JM (1997) Thymic function in HIV-1 disease. Semin. Immunol. 9:397–404.

  • McCune JM (1997) Animal models of HIV-1 disease. Science 278:2141–2142.

  • Miller MD, Warmerdam MT, Ferrell SS, Benitez R, Greene WC (1997) Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity. Virology 234:215–225.

  • Molden J, Chang Y, You Y, Moore PS, Goldsmith MA (1997) A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem. 272:19625–19631.

  • Powell DM, Amaral MC, Wu JY, Maniatis T, Greene WC (1997) HIV Rev-dependent binding of SF2/ASF to the Rev response element: Possible role in Rev-mediated inhibition of HIV RNA splicing. Proc. Natl. Acad. Sci. USA 94:973–978.

  • Sheridan PL, Mayall TP, Verdin E, Jones KA (1997) Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev. 11:3327–3340.

  • Sinclair E, Barbosa P, Feinberg MB (1997) The nef gene products of both simian and human immunodeficiency viruses enhance virus infectivity and are functionally interchangeable. J. Virol. 71:3641–3651.

  • Speck RF, Wehrly K, Platt EJ, Atchison RE, Charo IF, Kabat D, Chesebro B, Goldsmith MA (1997) Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71:7136–7139.

  • Stoddart CA (1997) SCID-hu Thy/Liv mouse model for evaluating HIV-1 antivirals. Int. Antiviral News 5:22–24.

  • Su L, Kaneshima H, Bonyhadi ML, Lee R, Auten J, Wolf A, Du B, Rabin L, Hahn BH, Terwilliger E, McCune JM (1997) Identification of HIV-1 determinants for replication in vivo. Virology 227:45–52.


Gladstone Home | Cardiovascular Disease | Virology and Immunology | Neurological Disease | Administration | UCSF